Hospitalised COVID-19 patients who received an inhaled form of an immune system protein were less likely to develop severe symptoms, according to a new study which may lead to a new treatment strategy against the disease. In the new study a formulation of interferon beta called SNG001 was directly delivered to the lungs via inhalation and its safety and efficacy …
)